日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring the regulatory mechanism of CCNA2 in colorectal cancer: Insights from multiomics and experimental analysis.

探索 CCNA2 在结直肠癌中的调控机制:来自多组学和实验分析的见解

Lei Xinyi, Qiu Lanying, Chen Qiang, Liao Lan, Yu Pengfei, Wu Wenjie, Zhu Zhengyang, Li Chunying, Lin Gang, Zhuang Zirui, Meng Yuxin, Wang Yan, Wang Cunchuan, Du Yian

Long term survival following cryoablation with adjuvant Toripalimab for anorectal malignant melanoma: a case report

冷冻消融联合托瑞普利单抗辅助治疗肛门直肠恶性黑色素瘤的长期生存:病例报告

Jiang, Xuejun; Ji, Zujin; Li, Peng; Yuan, Fangjun; Lei, Xinyi; Yang, Yong

Cryotherapy for low rectal and anal cancer: recommendation and indications

冷冻疗法治疗低位直肠癌和肛门癌:建议和适应症

Jiang, Xuejun; Ji, Zujin; Lei, Xinyi; He, Yingmei; Yuan, Fangjun

Immune Cytolytic Activity for Comprehensive Insights of the Immune Landscape in Endometrial Carcinoma

免疫细胞溶解活性对子宫内膜癌免疫图谱的全面揭示

Chen, Qiang; Wang, Chongyang; Lei, Xinyi; Huang, Ting; Zhou, Renyu; Lu, Yuanzhi

Characteristics of the Microbial Community in the Production of Chinese Rice-Flavor Baijiu and Comparisons With the Microflora of Other Flavors of Baijiu

中国米香白酒生产过程中微生物群落的特征及其与其他口味白酒微生物群落的比较

Hu, Yuanliang; Lei, Xinyi; Zhang, Xiaomin; Guan, Tongwei; Wang, Luyao; Zhang, Zongjie; Yu, Xiang; Tu, Junming; Peng, Nan; Liang, Yunxiang; Zhao, Shumiao

Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis

通过综合分析鉴定与肝癌预后、诊断、免疫浸润和治疗药物相关的关键基因

Lei, Xinyi; Zhang, Miao; Guan, Bingsheng; Chen, Qiang; Dong, Zhiyong; Wang, Cunchuan

Identification of core gene in obese type 2 diabetes patients using bioinformatics analysis

利用生物信息学分析鉴定肥胖型2型糖尿病患者的核心基因

Dong, Zhiyong; Lei, Xinyi; Kujawa, Stacy A; Bolu, NaciEmre; Zhao, Hong; Wang, Cunchuan

Glucocorticoid-Induced Leucine Zipper Protects the Retina From Light-Induced Retinal Degeneration by Inducing Bcl-xL in Rats

糖皮质激素诱导的亮氨酸拉链通过诱导大鼠中的 Bcl-xL 保护视网膜免受光诱导的视网膜变性

Ruiping Gu, Wenyi Tang, Boya Lei, Xinyi Ding, Cheng Jiang, Gezhi Xu